Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Reaffirmed by Cantor Fitzgerald
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “neutral” rating reissued by analysts at Cantor Fitzgerald in a report released on Monday, Benzinga reports. They currently have a $150.00 price objective on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective indicates a potential downside of 39.42% from the stock’s current price. A number […]
More Stories
Is Rosario Tijeras Season 5 Renewed? Release Date, Cast, and Synopsis
The popular Mexican television series or opera drama, Rosario Tijeras, is returning for its 5th season after getting a positive...
Pokémon Horizons Season 3: Release Date, Trailer, and Spoiler
Fan of the Pokémon series and desperately waiting for its release? Good News! Pokémon Horizons Season 3 is coming up...
Drew Carey Blast on Mayor Candidate, Spencer Pratt, called him a ‘Serial Scammer’
Drew Carey, a popular host, actor, and producer, has slammed the Los Angeles mayoral candidate, Spencer Pratt. On May 24,...
15+ Best Thrillers on Netflix: Movies and Television Series
Do you love to watch thriller shows and movies? Here, in this blog, I have mentioned the best thrillers on...
Maternal Instinct: A True Crime Documentary will release on Netflix this June
Do you also like true crime documentaries like The Investigation of Lucy Letby and Should I Marry a Murderer? Good...
You Can’t Skip These Roblox Competitors
Roblox has introduced millions of joystick junkies and developers to the world for creating amazing games and igniting their creative...